---  
layout: startup_page  
title: "Endovascular Engineering"  
id: "endovascularengineering.com"  
permalink: "/endovascularengineeringendovascularengineering.com02182025/"  
website: "https://endovascularengineering.com/"  
funding_round: "Series B"  
funding_amount: "$42M"  
investors: "415 Capital, S3 Ventures, Panakès Partners, M&L Healthcare, Santè Ventures, Cordis"  
about: "Endovascular Engineering (E2) is developing a next-generation clot removal technology platform focused on venous thromboembolism (VTE), with an initial focus on pulmonary embolism (PE). The company aims to revolutionize VTE treatment through its Hēlo™ PE Thrombectomy System, featuring a dual-action mechanism for efficient clot removal. E2's mission is to advance the standard of care in clot removal with its innovative technology platform."  
markets: "Healthtech, Medical Devices, Clinical Trials, Medical, Medical Device"  
hq: "Menlo Park, California, United States"  
founded_year: "2019"  
linkedin: "https://www.linkedin.com/company/endovascular-engineering"  
twitter: ""  
instagram: ""  
facebook: ""  
crunchbase: "https://www.crunchbase.com/organization/endovascular-engineering"  
pitchbook: "https://pitchbook.com/profiles/company/443251-63"  

date_display: "18-Feb-2025"  
date: "2025-02-18"

# SEO Optimization  
meta_title: "Endovascular Engineering - Series B Funding ($42M)"  
meta_description: "Endovascular Engineering, Endovascular Engineering (E2) is developing a next-generation clot removal technology platform focused on venous thromboembolism (VTE), with an initia..."  
meta_keywords: "Endovascular Engineering, Healthtech, Medical Devices, Clinical Trials, Medical, Medical Device, Series B funding"  
canonical_url: "https://startup.projectstartups.com/endovascularengineeringendovascularengineering.com02182025/"  
---